The EMBARK program represents the broad spectrum of ways in which therapeutic benefits might be experienced Program offers psychedelic clinical…
PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced its acquisition of a majority equity interests in each of Eh…
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced that its CEO…
Plant community brand builder PlantX Life Inc. is a growing e-commerce hub with over 5,000 products reflecting its focus on…
InnerScope Hearing Technologies (OTC: INND), a leader in direct-to-consumer (“DTC”) and over-the-counter (“OTC”) hearing solutions, is partnering with Atlazo Inc. The…
Events industry and global live streaming, two markets that Friendable’s flagship offering, Fan Pass, can leverage, are expected to grow…
Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has…
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) was featured in a recent “Bell2Bell” podcast episode in which CEO Hector Bremner discussed…
Friendable (OTC: FDBL), a mobile technology and marketing company, recently announced a unique opportunity for artists on the Fan Pass…
Hedge funds with artificial intelligence capabilities showed competitive edge over investors that didn’t use AI Top reason given for using…